We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
18 men participated in a 6-week controlled consumption study of a low-zinc, rice-based diet
Insights from new evidence on the relationship between excess weight and coronavirus (COVID-19).
The new presentation of Mounjaro gives four doses for once-a-week treatment over a month.
Guidance for living safely with respiratory infections, including coronavirus (COVID-19).
For the first time in the UK, obese patients and people who are overweight with weight-related health problems could now have access to Mounjaro, currently used for Type 2 diabetes, to help manage their weight and support weight loss.
Check the tariff classification for a heat and moisture exchanging filter.
Estimates the potential effect of increases in human weight, caused by rising BMI and height, on future calorie requirements
Helping public health practitioners conducting evaluations – using economic evaluation to identify the value gained from an intervention.
This tax information and impact note updates the lists of technologies and products covered by the energy-saving and water efficient enhanced capital allowances (ECA) schemes.
Guidance for people who have been diagnosed with a mpox infection and who have been advised to self-isolate at home.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (9 April 2024) approved the medicine fosdenopterin (Nulibry) to treat the genetic disease Molybdenum Cofactor Deficiency (MoCD) Type A
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).